Skyla Hi
Skyla Hi
2017

Share:

Skyla Hi

Analyzer

Lite-on Technology Corp.

The use of Skyla Hi in the management of diabetes enables better access to testing and rapid clinical decision making, discussion and implementation of optimized treatment. The HbA1c test only needs 0.8 µl of fingertips and venous blood. By highly efficient design, Skyla Hi allows two specimens tested in one run and verifies the validity of cartridge automatically. The testing result will come out in five minutes. Intuitive user-interface with 5" full-color touch screen makes users easy to operate. Additionally, it comes with a collecting area on the top of the device for storing both carrier and cartridge.

Date of Launch
2016
Development Time
up to 12 months
Target Regions
Asia, Europe, North America
Target Groups
Consumer / User

RELATED PROJECTS